Tanapox Virus Are That It Caused Should Not
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Specimen Type, Collection Methods, and Diagnostic Assays Available For
Specimen type, collection methods, and diagnostic assays available for the detection of poxviruses from human specimens by the Poxvirus and Rabies Branch, Centers for Disease Control and Prevention1. Specimen Orthopoxvirus Parapoxvirus Yatapoxvirus Molluscipoxvirus Specimen type collection method PCR6 Culture EM8 IHC9,10 Serology11 PCR12 EM8 IHC9,10 PCR13 EM8 PCR EM8 Lesion material Fresh or frozen Swab 5 Lesion material [dry or in media ] [vesicle / pustule Formalin fixed skin, scab / crust, etc.] Paraffin block Fixed slide(s) Container Lesion fluid Swab [vesicle / pustule [dry or in media5] fluid, etc.] Touch prep slide Blood EDTA2 EDTA tube 7 Spun or aliquoted Serum before shipment Spun or aliquoted Plasma before shipment CSF3,4 Sterile 1. The detection of poxviruses by electron microscopy (EM) and immunohistochemical staining (IHC) is performed by the Infectious Disease Pathology Branch of the CDC. 2. EDTA — Ethylenediaminetetraacetic acid. 3. CSF — Cerebrospinal fluid. 4. In order to accurately interpret test results generated from CSF specimens, paired serum must also be submitted. 5. If media is used to store and transport specimens a minimal amount should be used to ensure as little dilution of DNA as possible. 6. Orthopoxvirus generic real-time polymerase chain reaction (PCR) assays will amplify DNA from numerous species of virus within the Orthopoxvirus genus. Species-specific real-time PCR assays are available for selective detection of DNA from variola virus, vaccinia virus, monkeypox virus, and cowpox virus. 7. Blood is not ideal for the detection of orthopoxviruses by PCR as the period of viremia has often passed before sampling occurs. 8. EM can reveal the presence of a poxvirus in clinical specimens or from virus culture, but this technique cannot differentiate between virus species within the same genus. -
The Approved List of Biological Agents Advisory Committee on Dangerous Pathogens Health and Safety Executive
The Approved List of biological agents Advisory Committee on Dangerous Pathogens Health and Safety Executive © Crown copyright 2021 First published 2000 Second edition 2004 Third edition 2013 Fourth edition 2021 You may reuse this information (excluding logos) free of charge in any format or medium, under the terms of the Open Government Licence. To view the licence visit www.nationalarchives.gov.uk/doc/ open-government-licence/, write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email [email protected]. Some images and illustrations may not be owned by the Crown so cannot be reproduced without permission of the copyright owner. Enquiries should be sent to [email protected]. The Control of Substances Hazardous to Health Regulations 2002 refer to an ‘approved classification of a biological agent’, which means the classification of that agent approved by the Health and Safety Executive (HSE). This list is approved by HSE for that purpose. This edition of the Approved List has effect from 12 July 2021. On that date the previous edition of the list approved by the Health and Safety Executive on the 1 July 2013 will cease to have effect. This list will be reviewed periodically, the next review is due in February 2022. The Advisory Committee on Dangerous Pathogens (ACDP) prepares the Approved List included in this publication. ACDP advises HSE, and Ministers for the Department of Health and Social Care and the Department for the Environment, Food & Rural Affairs and their counterparts under devolution in Scotland, Wales & Northern Ireland, as required, on all aspects of hazards and risks to workers and others from exposure to pathogens. -
Risk Groups: Viruses (C) 1988, American Biological Safety Association
Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII Flaviviridae/ Flavivirus (Grp 2 Absettarov, TBE 4 4 4 implied 3 3 4 + B Arbovirus) Acute haemorrhagic taxonomy 2, Enterovirus 3 conjunctivitis virus Picornaviridae 2 + different 70 (AHC) Adenovirus 4 Adenoviridae 2 2 (incl animal) 2 2 + (human,all types) 5 Aino X-Arboviruses 6 Akabane X-Arboviruses 7 Alastrim Poxviridae Restricted 4 4, Foot-and- 8 Aphthovirus Picornaviridae 2 mouth disease + viruses 9 Araguari X-Arboviruses (feces of children 10 Astroviridae Astroviridae 2 2 + + and lambs) Avian leukosis virus 11 Viral vector/Animal retrovirus 1 3 (wild strain) + (ALV) 3, (Rous 12 Avian sarcoma virus Viral vector/Animal retrovirus 1 sarcoma virus, + RSV wild strain) 13 Baculovirus Viral vector/Animal virus 1 + Togaviridae/ Alphavirus (Grp 14 Barmah Forest 2 A Arbovirus) 15 Batama X-Arboviruses 16 Batken X-Arboviruses Togaviridae/ Alphavirus (Grp 17 Bebaru virus 2 2 2 2 + A Arbovirus) 18 Bhanja X-Arboviruses 19 Bimbo X-Arboviruses Blood-borne hepatitis 20 viruses not yet Unclassified viruses 2 implied 2 implied 3 (**)D 3 + identified 21 Bluetongue X-Arboviruses 22 Bobaya X-Arboviruses 23 Bobia X-Arboviruses Bovine 24 immunodeficiency Viral vector/Animal retrovirus 3 (wild strain) + virus (BIV) 3, Bovine Bovine leukemia 25 Viral vector/Animal retrovirus 1 lymphosarcoma + virus (BLV) virus wild strain Bovine papilloma Papovavirus/ -
By: Evita Mayasari, Dr., Mkes. Microbiology Department Medical School University of Sumatera Utara
PART 1 by: Evita Mayasari, dr., MKes. Microbiology Department Medical School University of Sumatera Utara 1 Zoonoses (“zoonosis” is singular) are diseases the agents of which are transmitted between vertebrate animals and people. animals play an essential role in maintaining the infection in nature, and man is only an accidental host. Reservoir (of zoonoses): vertebrate that provides a pathogen with adequate conditions for survival and multiplication and opportunity for transmission. 2 Argentine Hemorrhagic Fever Ebola Hemorrhagic Fever (EHF) (AHF) Encephalomyocarditis (EMC) Bolivian Hemorrhagic Fever Hantavirus Pulmonary (BHF) Syndrome (HPS) Bovine Papular Stomatitis (BPS) Hantavirus Renal Syndromes California (Lacrosse) Herpesvirus simiae (B) Infection Encephalitis Influenza Japanese (B) Encephalitis (JBE) Colorado Tick Fever (CTF) Kyasanur Forest Disease (KFD) Contagious Ecthyma Lassa Fever (LF) Cowpox Louping Ill Crimean-CongoHemorrhagic Lymphocytic Choriomeningitis Fever (CCHF) (LCM) Eastern Equine Encephalitis Marburg Disease (EEE) Monkeypox 3 Murray Valley Encephalitis Sicilian Sandfly Fever (MVE) Tanapox Nairobi Sheep Disease Venezuelan Equine (NSD) Newcastle Disease Encephalitis (VEE) (ND) Vesicular Stomatitis (VS) Omsk Hemorrhagic Fever Viral Hepatitis Type A , B, C, (OHF) a D, E Pseudocowpox Wesselsbron Disease Rabies (WSL) Rift Valley Fever (RVF) Western Equine Russian Spring-Summer Encephalitis (WEE) Encephalitis (RSSE) West Nile Fever (WNF) St. Louis Encephalitis (SLE) Yabapox Yellow Fever (YF) Zoonoses: Recognition, Control, and Prevention. 1995, Iowa State University Press 4 >50,000 DEATHS PER YEAR WORLD WIDE Rabies virus particles 5 Family:Rhabdoviridae Genus: Lyssavirus Species :Rabies virus helical, enveloped Group V (( -)ssRNA) , Structure of rabies virus 11-12 kb 6 Serotype 1: The category that includes most of the viruses that cause rabies in man and animals, as well as laboratory fixed viruses. -
Zoonotic Potential of International Trade in CITES-Listed Species Annexes B, C and D JNCC Report No
Zoonotic potential of international trade in CITES-listed species Annexes B, C and D JNCC Report No. 678 Zoonotic potential of international trade in CITES-listed species Annex B: Taxonomic orders and associated zoonotic diseases Annex C: CITES-listed species and directly associated zoonotic diseases Annex D: Full trade summaries by taxonomic family UNEP-WCMC & JNCC May 2021 © JNCC, Peterborough 2021 Zoonotic potential of international trade in CITES-listed species Prepared for JNCC Published May 2021 Copyright JNCC, Peterborough 2021 Citation UNEP-WCMC and JNCC, 2021. Zoonotic potential of international trade in CITES- listed species. JNCC Report No. 678, JNCC, Peterborough, ISSN 0963-8091. Contributing authors Stafford, C., Pavitt, A., Vitale, J., Blömer, N., McLardy, C., Phillips, K., Scholz, L., Littlewood, A.H.L, Fleming, L.V. & Malsch, K. Acknowledgements We are grateful for the constructive comments and input from Jules McAlpine (JNCC), Becky Austin (JNCC), Neville Ash (UNEP-WCMC) and Doreen Robinson (UNEP). We also thank colleagues from OIE for their expert input and review in relation to the zoonotic disease dataset. Cover Photographs Adobe Stock images ISSN 0963-8091 JNCC Report No. 678: Zoonotic potential of international trade in CITES-listed species Annex B: Taxonomic orders and associated zoonotic diseases Annex B: Taxonomic orders and associated zoonotic diseases Table B1: Taxonomic orders1 associated with at least one zoonotic disease according to the source papers, ranked by number of associated zoonotic diseases identified. -
Commission Directive (Eu)
L 279/54 EN Offi cial Jour nal of the European Union 31.10.2019 COMMISSION DIRECTIVE (EU) 2019/1833 of 24 October 2019 amending Annexes I, III, V and VI to Directive 2000/54/EC of the European Parliament and of the Council as regards purely technical adjustments THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (1), and in particular Article 19 thereof, Whereas: (1) Principle 10 of the European Pillar of Social Rights (2), proclaimed at Gothenburg on 17 November 2017, provides that every worker has the right to a healthy, safe and well-adapted working environment. The workers’ right to a high level of protection of their health and safety at work and to a working environment that is adapted to their professional needs and that enables them to prolong their participation in the labour market includes protection from exposure to biological agents at work. (2) The implementation of the directives related to the health and safety of workers at work, including Directive 2000/54/EC, was the subject of an ex-post evaluation, referred to as a REFIT evaluation. The evaluation looked at the directives’ relevance, at research and at new scientific knowledge in the various fields concerned. The REFIT evaluation, referred to in the Commission Staff Working Document (3), concludes, among other things, that the classified list of biological agents in Annex III to Directive 2000/54/EC needs to be amended in light of scientific and technical progress and that consistency with other relevant directives should be enhanced. -
Parechovirus B)
Department of Virology Faculty of Medicine, University of Helsinki Doctoral Program in Biomedicine Doctoral School in Health Sciences DISTRIBUTION AND CLINICAL ASSOCIATIONS OF LJUNGAN VIRUS (PARECHOVIRUS B) CRISTINA FEVOLA ACADEMIC DISSERTATION To be presented for public examination with the permission of the Faculty of Medicine, University of Helsinki, in lecture hall LS1, on 11 01 19, at noon Helsinki 2019 Supervisors: Anne J. Jääskeläinen, PhD, Docent, Department of Virology University of Helsinki and Helsinki University Hospital Helsinki, Finland Antti Vaheri, MD, PhD, Professor Department of Virology Faculty of Medicine, University of Helsinki Finland & Heidi C. Hauffe, RhSch, DPhil (Oxon), Researcher Department of Biodiversity and Molecular Ecology Research and Innovation Centre, Fondazione Edmund Mach San Michele all’Adige, TN Italy Reviewers: Laura Kakkola, PhD, Docent Institute of Biomedicine Faculty of Medicine, University of Turku Turku, Finland & Petri Susi, PhD, Docent Institute of Biomedicine Faculty of Medicine, University of Turku Turku, Finland Official opponent: Detlev Krüger, MD, PhD, Professor Institute of Medical Virology Helmut-Ruska-Haus University Hospital Charité Berlin, Germany Cover photo: Cristina Fevola, The Pala group (Italian: Pale di San Martino), a mountain range in the Dolomites, in Trentino Alto Adige, Italy. ISBN 978-951-51-4748-6 (paperback) ISBN 978-951-51-4749-3 (PDF, available at http://ethesis.helsinki.fi) Unigrafia Oy, Helsinki, Finland 2019 To you the reader, for being curious. Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less. Marie Curie TABLE OF CONTENTS LIST OF ORIGINAL PUBLICATIONS ................................................................................................. 5 LIST OF ABBREVIATIONS ............................................................................................................... -
The Partial Characterization of the 142R Protein of Tanapox Virus
Western Michigan University ScholarWorks at WMU Dissertations Graduate College 12-2013 The Partial Characterization of the 142R Protein of Tanapox Virus Krystal N. Seibert Western Michigan University, [email protected] Follow this and additional works at: https://scholarworks.wmich.edu/dissertations Part of the Virus Diseases Commons Recommended Citation Seibert, Krystal N., "The Partial Characterization of the 142R Protein of Tanapox Virus" (2013). Dissertations. 217. https://scholarworks.wmich.edu/dissertations/217 This Dissertation-Open Access is brought to you for free and open access by the Graduate College at ScholarWorks at WMU. It has been accepted for inclusion in Dissertations by an authorized administrator of ScholarWorks at WMU. For more information, please contact [email protected]. THE PARTIAL CHARACTERIZATION OF THE 142R PROTEIN OF TANAPOX VIRUS by Krystal N. Seibert A dissertation submitted to the Graduate College in partial fulfillment of the requirements for the degree of Doctor of Philosophy Biological Sciences Western Michigan University December 2013 Doctoral Committee: Bruce Bejcek, Ph.D., Chair John Geiser, Ph.D. Neal Goodwin, Ph.D. THE PARTIAL CHARACTERIZATION OF THE 142R PROTEIN OF TANAPOX VIRUS Krystal N. Seibert, Ph.D. Western Michigan University, 2013 Due to the complex nature of cancer, a variety of strategies are being employed to treat patients. Among these are oncolytic viruses that conditionally replicate in tumor cells with specific cellular landscapes. Several viruses including Herpesviruses, Adenoviruses, and Poxviruses, predominantly vaccinia virus (VV), have been explored for their oncolytic potential. Most of these viruses can productively infect a variety of cell types and it is one goal to create conditionally lethal viruses that can only replicate in tumor cells. -
B Directive 2000/54/Ec of the European
02000L0054 — EN — 24.06.2020 — 002.001 — 1 This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document ►B DIRECTIVE 2000/54/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC) (OJ L 262, 17.10.2000, p. 21) Amended by: Official Journal No page date ►M1 Commission Directive (EU) 2019/1833 of 24 October 2019 L 279 54 31.10.2019 ►M2 Commission Directive (EU) 2020/739 of 3 June 2020 L 175 11 4.6.2020 02000L0054 — EN — 24.06.2020 — 002.001 — 2 ▼B DIRECTIVE 2000/54/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC) CHAPTER I GENERAL PROVISIONS Article 1 Objective 1. This Directive has as its aim the protection of workers against risks to their health and safety, including the prevention of such risks, arising or likely to arise from exposure to biological agents at work. -
Viruses Status January 2013 FOEN/FOPH 2013 1
Classification of Organisms. Part 2: Viruses Status January 2013 FOEN/FOPH 2013 1 Authors: Prof. Dr. Riccardo Wittek, Dr. Karoline Dorsch-Häsler, Julia Link > Classification of Organisms Part 2: Viruses The classification of viruses was first published in 2005 and revised in 2010. Classification of Organisms. Part 2: Viruses Status January 2013 FOEN/FOPH 2013 2 Name Group Remarks Adenoviridae Aviadenovirus (Avian adenoviruses) Duck adenovirus 2 TEN Duck adenovirus 2 2 PM Fowl adenovirus A 2 Fowl adenovirus 1 (CELO, 112, Phelps) 2 PM Fowl adenovirus B 2 Fowl adenovirus 5 (340, TR22) 2 PM Fowl adenovirus C 2 Fowl adenovirus 10 (C-2B, M11, CFA20) 2 PM Fowl adenovirus 4 (KR-5, J-2) 2 PM Fowl adenovirus D 2 Fowl adenovirus 11 (380) 2 PM Fowl adenovirus 2 (GAL-1, 685, SR48) 2 PM Fowl adenovirus 3 (SR49, 75) 2 PM Fowl adenovirus 9 (A2, 90) 2 PM Fowl adenovirus E 2 Fowl adenovirus 6 (CR119, 168) 2 PM Fowl adenovirus 7 (YR36, X-11) 2 PM Fowl adenovirus 8a (TR59, T-8, CFA40) 2 PM Fowl adenovirus 8b (764, B3) 2 PM Goose adenovirus 2 Goose adenovirus 1-3 2 PM Pigeon adenovirus 2 PM TEN Turkey adenovirus 2 TEN Turkey adenovirus 1, 2 2 PM Mastadenovirus (Mammalian adenoviruses) Bovine adenovirus A 2 Bovine adenovirus 1 2 PM Bovine adenovirus B 2 Bovine adenovirus 3 2 PM Bovine adenovirus C 2 Bovine adenovirus 10 2 PM Canine adenovirus 2 Canine adenovirus 1,2 2 PM Caprine adenovirus 2 TEN Goat adenovirus 1, 2 2 PM Equine adenovirus A 2 Equine adenovirus 1 2 PM Equine adenovirus B 2 Equine adenovirus 2 2 PM Classification of Organisms. -
Chapter 29. Human Monkeypox and Other Poxvirus Infections of Man
CHAPTER 29 HUMAN MONKEYPOX AND OTHER POXVIRUS INFECTIONS OF MAN Contents Page Introduction 1287 Monkeypox in captive primates 1288 The properties of monkeypox virus 1290 Pathogenicity for laboratory animals 1290 Comparison of DNA maps of strains of monkeypox virus 1290 Genetic studies 1291 Species diagnosis 1292 Serological diagnosis of past monkeypox infection 1292 Human monkeypox 1292 Discovery of human infections 1292 Organization of laboratory research 1293 Organization of field research 1295 Incidence and distribution 1295 Clinical features 1297 Epidemiology 1303 Ecological studies 1308 Monkeypox : the overall picture 1311 Other Orthopoxvirus infections of man 1311 Vaccinia 1311 Cowpox 1312 Camelpox 1316 Parapoxvirus infections 1316 Molluscum contagiosum 1317 Tanapox virus infections 1318 General comment 1319 INTRODUCTION mild symptoms and usually only a localized skin lesion, the diseases in question presented Human monkeypox was first recognized in a potential diagnostic problem during the 1970 ; it is a severe systemic disease with a global eradication of smallpox, since virus generalized pustular rash, clinically indistin- particles found in lesions by electron micro- guishable from smallpox. In addition to va- scopic examination could be confused with riola and monkeypox viruses, 7 other species those of variola virus. Because of its import- of poxvirus, of 4 genera, can cause lesions in ance, monkeypox is the main subject of this man (Table 29 .1). Although infection with chapter, but a brief description is given of each of -
Taxonomy Bovine Ephemeral Fever Virus Kotonkan Virus Murrumbidgee
Taxonomy Bovine ephemeral fever virus Kotonkan virus Murrumbidgee virus Murrumbidgee virus Murrumbidgee virus Ngaingan virus Tibrogargan virus Circovirus-like genome BBC-A Circovirus-like genome CB-A Circovirus-like genome CB-B Circovirus-like genome RW-A Circovirus-like genome RW-B Circovirus-like genome RW-C Circovirus-like genome RW-D Circovirus-like genome RW-E Circovirus-like genome SAR-A Circovirus-like genome SAR-B Dragonfly larvae associated circular virus-1 Dragonfly larvae associated circular virus-10 Dragonfly larvae associated circular virus-2 Dragonfly larvae associated circular virus-3 Dragonfly larvae associated circular virus-4 Dragonfly larvae associated circular virus-5 Dragonfly larvae associated circular virus-6 Dragonfly larvae associated circular virus-7 Dragonfly larvae associated circular virus-8 Dragonfly larvae associated circular virus-9 Marine RNA virus JP-A Marine RNA virus JP-B Marine RNA virus SOG Ostreid herpesvirus 1 Pig stool associated circular ssDNA virus Pig stool associated circular ssDNA virus GER2011 Pithovirus sibericum Porcine associated stool circular virus Porcine stool-associated circular virus 2 Porcine stool-associated circular virus 3 Sclerotinia sclerotiorum hypovirulence associated DNA virus 1 Wallerfield virus AKR (endogenous) murine leukemia virus ARV-138 ARV-176 Abelson murine leukemia virus Acartia tonsa copepod circovirus Adeno-associated virus - 1 Adeno-associated virus - 4 Adeno-associated virus - 6 Adeno-associated virus - 7 Adeno-associated virus - 8 African elephant polyomavirus